Intimation for Dividend recommendation.
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rainbow Children's Medicare reported strong FY2026 results with standalone revenue of Rs 15,457 million (up 6.3% YoY) and consolidated revenue of Rs 17,031 million (up 12.4% YoY). Consolidated profit after tax grew 15.3% to Rs 2,815 million from Rs 2,442 million. The Board recommended a final dividend of Rs 3.5 per equity share (35% payout on Rs 10 face value), totaling Rs 355.46 million, subject to shareholder approval at the 28th AGM on July 29, 2026. An exceptional item of Rs 15.39 million was recognized due to New Labour Codes implementation. The statutory auditors issued unmodified opinions on both standalone and consolidated financial results. The company also announced re-appointment of key management including Chairman Dr. Ramesh Kancharla and two independent directors.
The dividend recommendation signals company's financial stability and cash generation capability. The 15.3% PAT growth on consolidated basis demonstrates solid operational performance though below 25% threshold. The clean audit opinions indicate no going concern issues. Shareholders can expect dividend payment if approved at AGM.